Target | Mutation | Consequence | Tumor Type | Reference |
---|---|---|---|---|
Cyclin D1 | T286R | Constitutively Nuclear | Esophageal | [18] |
Cyclin D1 | Δ266–295 | Constitutively Nuclear | Esophageal | [18] |
Cyclin D1 | P287A | Constitutively Nuclear | Tumor-derived esophageal carcinoma cell lines TE3, TE7, and TE12 | [18] |
Cyclin D1 | P287S/T | Constitutively Nuclear | Endometrial | [17] |
Cyclin D1 | Δ289–292 | Constitutively Nuclear | Endometrial | [17] |
αB crystallin | Chromosome 11 deletion | Impaired ligase activity | Tumor-derived breast cancer cell lines (MCF-7, MDA-MB 231) | [14] |
Fbx4 | S8R | Impaired ligase activity | Esophageal | [26] |
Fbx4 | S12L | Disrupts phosphorylation | Esophageal | [26] |
Fbx4 | P13S | Disrupts phosphorylation | Esophageal | [26] |
Fbx4 | L23Q | Dimerization-deficient | Esophageal | [26] |
Fbx4 | P76T | Impaired Skp1 binding | Esophageal | [26] |